GlaxoSmithKline Consumer Healthcare has informed about the Certificate issued by Registrar and Share Transfer Agents certifying that the requirements under Regulation 7(2) are complied with for the half year ended march 31, 2018 along with Compliance Certificate signed by Company Secretary of the Company.
The above information is a part of company’s filings submitted to BSE.